Clinical Trials Logo

Ewing's Family Tumors clinical trials

View clinical trials related to Ewing's Family Tumors.

Filter by:
  • None
  • Page 1

NCT ID: NCT01505569 Completed - Soft Tissue Sarcoma Clinical Trials

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Start date: October 20, 2011
Phase: N/A
Study type: Interventional

This is a standard of care treatment guideline for high risk or relapsed solid tumors or CNS tumors consisting of a busulfan, melphalan, thiotepa conditioning (for solid tumors) or carboplatin and thiotepa conditioning (for CNS tumors) followed by an autologous peripheral blood stem cell transplant. For solid tumors, if appropriate, disease specific radiation therapy at day +60. For CNS tumors, the conditioning regimen and autologous peripheral blood stem cell transplant will be given for 3 cycles.